Context

Founded in 1997 by Dr. h.c. Thomas Straumman, Medartis Holding AG headquartered in Basel, Switzerland, is a leading manufacturer and provider of medical devices for internal surgical bone fixation.

Medartis specializes in fixation solutions that comprise technical high-precision titanium screws, plates, and surgical instruments for bone fractures fixation and osteotomies of the hand, wrist, elbow, foot, ankle as well as the head.

The company sells its products in 44 countries - including Switzerland, Germany, France, the United States, Japan, Australia and Brazil - directly through its headquarters and 11 subsidiaries, and via distributors.

The funds will in particular help intensify commercialization efforts in the US in order to accelerate growth and increase the market share as well as sustain the commercial launch of products in new territories, including Japan and China.

About Medartis

Founded in 1997 and headquartered in Basel, Switzerland, Medartis is one of the world’s leading manufacturers and providers of medical devices for surgical fixation of bone fractures and osteotomies for the craniofacial region as well as for upper and lower extremities. Medartis employs over 480 individuals across its 11 locations, and Medartis products are sold in 44 countries globally. For patients’ welfare, Medartis is committed to providing surgeons and operating theatre personnel with the most innovative titanium implants and instruments as well as best in class services that represent advances in osteosynthesis.

Discover Medartis

Olivier Garnier

Investment Banking

Dr. Anne Moore

Investment Banking

Remi Negre

Investment Banking

Pierre Kiecolt-Wahl

Investment Banking

Jean de Pracomtal

Investment Banking

Deal Team

Should you want to know more about this transaction, you can contact one of the team members above

Privacy Preference Center